Clinical trials show that 515% of patients experience mild to moderate fatigue, with the highest rates during dose escalation phases
Here, after metformin failure, GLP-1 receptor agonists, or SGLT-2 inhibitors are recommended as second line therapy or as third line therapy in combination
Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR axis
Keywords: Tirazepatide, Glucose-dependent insulinotropic polypeptide, Glucagon-like peptide-1 Introduction The most likely origin of an acute respiratory illness known as coronavirus disease in 2019 (Covid-19) is a new coronavirus known as severe acute respiratory syndrome CoV type 2 (SARS-CoV-2) (Al-kuraishy et al
Theobromine (100mg): Natural mood and energy enhancer from cacao
This study identified raised NF-B levels in the rat colon, which was consistent with the findings of Ala et al